Literature DB >> 25003769

Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease.

J Charles Jennette1, Ronald J Falk1.   

Abstract

Antineutrophil cytoplasmic autoantibodies (ANCAs) are the probable cause of a distinct form of vasculitis that can be accompanied by necrotizing granulomatosis. Clinical and experimental evidence supports a pathogenesis that is driven by ANCA-induced activation of neutrophils and monocytes, producing destructive necrotizing vascular and extravascular inflammation. Pathogenic ANCAs can originate from precursor natural autoantibodies. Pathogenic transformation might be initiated by commensal or pathogenic microbes, legal or illegal drugs, exogenous or endogenous autoantigen complementary peptides, or dysregulated autoantigen expression. The ANCA autoimmune response is facilitated by insufficient T-cell and B-cell regulation. A putative pathogenic mechanism for vascular inflammation begins with ANCA-induced activation of primed neutrophils and monocytes leading to activation of the alternative complement pathway, which sets in motion an inflammatory amplification loop in the vessel wall that attracts and activates neutrophils with resultant respiratory burst, degranulation, extrusion of neutrophil extracellular traps, apoptosis and necrosis. The pathogenesis of extravascular granulomatosis is less clear, but a feasible scenario proposes that a prodromal infectious or allergic condition positions primed neutrophils in extravascular tissue in which they can be activated by ANCAs in interstitial fluid to produce extravascular necrotizing injury that would initiate an innate granulomatous inflammatory response to wall off the necrotic debris.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25003769     DOI: 10.1038/nrrheum.2014.103

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


  100 in total

1.  The rise and fall of horror autotoxicus and forbidden clones.

Authors:  J Charles Jennette; Ronald J Falk
Journal:  Kidney Int       Date:  2010-09       Impact factor: 10.612

2.  Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, alpha1-antitrypsin, and Fcgamma receptors.

Authors:  D R Ralston; C B Marsh; M P Lowe; M D Wewers
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

3.  Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis.

Authors:  Sophia Lionaki; Elizabeth R Blyth; Susan L Hogan; Yichun Hu; Brent A Senior; Caroline E Jennette; Patrick H Nachman; J Charles Jennette; Ronald J Falk
Journal:  Arthritis Rheum       Date:  2012-10

4.  Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha.

Authors:  Dennis Huugen; Hong Xiao; Anita van Esch; Ronald J Falk; Carine J Peutz-Kootstra; Wim A Buurman; Jan Willem Cohen Tervaert; J Charles Jennette; Peter Heeringa
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

5.  Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies.

Authors:  Adrian Schreiber; Hong Xiao; Ronald J Falk; J Charles Jennette
Journal:  J Am Soc Nephrol       Date:  2006-11-15       Impact factor: 10.121

6.  Circumvention of normal constraints on granule protein gene expression in peripheral blood neutrophils and monocytes of patients with antineutrophil cytoplasmic autoantibody-associated glomerulonephritis.

Authors:  Jia Jin Yang; William F Pendergraft; David A Alcorta; Patrick H Nachman; Susan L Hogan; Robin P Thomas; Pamela Sullivan; J Charles Jennette; Ronald J Falk; Gloria A Preston
Journal:  J Am Soc Nephrol       Date:  2004-08       Impact factor: 10.121

7.  Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo.

Authors:  Heiko Pfister; Markus Ollert; Leopold F Fröhlich; Leticia Quintanilla-Martinez; Thomas V Colby; Ulrich Specks; Dieter E Jenne
Journal:  Blood       Date:  2004-05-18       Impact factor: 22.113

8.  Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils.

Authors:  R Goldschmeding; C E van der Schoot; D ten Bokkel Huinink; C E Hack; M E van den Ende; C G Kallenberg; A E von dem Borne
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

Review 9.  Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis.

Authors:  William F Pendergraft; John L Niles
Journal:  Curr Opin Rheumatol       Date:  2014-01       Impact factor: 5.006

Review 10.  Staphylococcus aureus and Wegener's granulomatosis.

Authors:  Eliane R Popa; Coen A Stegeman; Cees G M Kallenberg; Jan Willem Cohen Tervaert
Journal:  Arthritis Res       Date:  2001-10-26
View more
  142 in total

1.  Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN.

Authors:  Sanjeev Sethi; Mark Haas; Glen S Markowitz; Vivette D D'Agati; Helmut G Rennke; J Charles Jennette; Ingeborg M Bajema; Charles E Alpers; Anthony Chang; Lynn D Cornell; Fernando G Cosio; Agnes B Fogo; Richard J Glassock; Sundaram Hariharan; Neeraja Kambham; Donna J Lager; Nelson Leung; Michael Mengel; Karl A Nath; Ian S Roberts; Brad H Rovin; Surya V Seshan; Richard J H Smith; Patrick D Walker; Christopher G Winearls; Gerald B Appel; Mariam P Alexander; Daniel C Cattran; Carmen Avila Casado; H Terence Cook; An S De Vriese; Jai Radhakrishnan; Lorraine C Racusen; Pierre Ronco; Fernando C Fervenza
Journal:  J Am Soc Nephrol       Date:  2015-11-13       Impact factor: 10.121

Review 2.  Necroinflammation in Kidney Disease.

Authors:  Shrikant R Mulay; Andreas Linkermann; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2015-09-02       Impact factor: 10.121

Review 3.  The Contribution of PTPN22 to Rheumatic Disease.

Authors:  Tomas Mustelin; Nunzio Bottini; Stephanie M Stanford
Journal:  Arthritis Rheumatol       Date:  2019-03-02       Impact factor: 10.995

4.  ANCA positivity at the time of renal biopsy is associated with chronicity index of lupus nephritis.

Authors:  Jung Yoon Pyo; Seung Min Jung; Jason Jungsik Song; Yong-Beom Park; Sang-Won Lee
Journal:  Rheumatol Int       Date:  2019-02-26       Impact factor: 2.631

5.  Role of Macrophage Migration Inhibitory Factor in Granulomatosis With Polyangiitis.

Authors:  Antoine G Sreih; Rana Ezzedine; Lin Leng; Juan Fan; Jie Yao; Duncan Reid; Marta Piecychna; Simon Carette; David Cuthbertson; Paul Dellaripa; Gary S Hoffman; Nader A Khalidi; Curry L Koening; Carol A Langford; Alfred Mahr; Carol A McAlear; Kathleen Maksimowicz-Mckinnon; Paul A Monach; Philip Seo; Ulrich Specks; E William St Clair; John H Stone; Steven R Ytterberg; Jeffrey Edberg; Peter A Merkel; Richard Bucala
Journal:  Arthritis Rheumatol       Date:  2018-10-22       Impact factor: 10.995

6.  TLR9 Deficiency Leads to Accelerated Renal Disease and Myeloid Lineage Abnormalities in Pristane-Induced Murine Lupus.

Authors:  Lukas Bossaller; Anette Christ; Karin Pelka; Kerstin Nündel; Ping-I Chiang; Catherine Pang; Neha Mishra; Patricia Busto; Ramon G Bonegio; Reinhold Ernst Schmidt; Eicke Latz; Ann Marshak-Rothstein
Journal:  J Immunol       Date:  2016-06-27       Impact factor: 5.422

7.  Neutrophil extracellular traps as a potential source of autoantigen in cocaine-associated autoimmunity.

Authors:  Christian Lood; Grant C Hughes
Journal:  Rheumatology (Oxford)       Date:  2017-04-01       Impact factor: 7.580

8.  [Effector memory T‑cells in the pathogenesis of ANCA-associated vasculitides. German version].

Authors:  A Kerstein; A Müller; D Kabelitz; P Lamprecht
Journal:  Z Rheumatol       Date:  2016-03       Impact factor: 1.372

Review 9.  ANCA-associated vasculitis with renal involvement.

Authors:  Valentina Binda; Gabriella Moroni; Piergiorgio Messa
Journal:  J Nephrol       Date:  2017-05-30       Impact factor: 3.902

10.  Inhibitory Anti-Peroxidasin Antibodies in Pulmonary-Renal Syndromes.

Authors:  A Scott McCall; Gautam Bhave; Vadim Pedchenko; Jacob Hess; Meghan Free; Dustin J Little; Thomas P Baker; William F Pendergraft; Ronald J Falk; Stephen W Olson; Billy G Hudson
Journal:  J Am Soc Nephrol       Date:  2018-10-02       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.